Published in Hum Brain Mapp on August 28, 2014
Decreased Default Mode Network connectivity correlates with age-associated structural and cognitive changes. Front Aging Neurosci (2014) 0.91
Resting-state functional connectivity of the striatum in early-stage Parkinson's disease: Cognitive decline and motor symptomatology. Hum Brain Mapp (2015) 0.81
Default mode network differences between rigidity- and tremor-predominant Parkinson's disease. Cortex (2016) 0.79
Alteration of Basal Ganglia and Right Frontoparietal Network in Early Drug-Naïve Parkinson's Disease during Heat Pain Stimuli and Resting State. Front Hum Neurosci (2015) 0.79
Resting state in Parkinson's disease dementia and dementia with Lewy bodies: commonalities and differences. Int J Geriatr Psychiatry (2015) 0.77
Genetic and Environmental Contributions to Functional Connectivity Architecture of the Human Brain. Cereb Cortex (2016) 0.77
Increased connectivity between sensorimotor and attentional areas in Parkinson's disease. Neuroradiology (2015) 0.77
Functional connectivity changes in adults with developmental stuttering: a preliminary study using quantitative electro-encephalography. Front Hum Neurosci (2014) 0.76
Discriminating cognitive status in Parkinson's disease through functional connectomics and machine learning. Sci Rep (2017) 0.75
Patterns of Longitudinal Neural Activity Linked to Different Cognitive Profiles in Parkinson's Disease. Front Aging Neurosci (2016) 0.75
Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's disease. Neuroimage Clin (2017) 0.75
Changes in functional organization and white matter integrity in the connectome in Parkinson's disease. Neuroimage Clin (2016) 0.75
Parkinson's disease-related network topographies characterized with resting state functional MRI. Hum Brain Mapp (2016) 0.75
Dysfunction of the Default Mode Network in Drug-Naïve Parkinson's Disease with Mild Cognitive Impairments: A Resting-State fMRI Study. Front Aging Neurosci (2016) 0.75
Compensatory striatal-cerebellar connectivity in mild-moderate Parkinson's disease. Neuroimage Clin (2015) 0.75
Altered functional connectivity in patients with post-stroke memory impairment: A resting fMRI study. Exp Ther Med (2017) 0.75
Psychosis in parkinsonism: an unorthodox approach. Neuropsychiatr Dis Treat (2017) 0.75
Aberrant Intrinsic Activity and Connectivity in Cognitively Normal Parkinson's Disease. Front Aging Neurosci (2017) 0.75
Altered Network Topology in Patients with Primary Brain Tumors After Fractionated Radiotherapy. Brain Connect (2017) 0.75
Default-mode network connectivity in cognitively unimpaired drug-naïve patients with rigidity-dominant Parkinson's disease. J Neurol (2016) 0.75
Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord (2007) 6.92
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol (2008) 6.76
A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med (2009) 5.81
Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol (2006) 4.72
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord (2007) 3.48
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. Lancet Neurol (2010) 3.15
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial. Lancet Neurol (2007) 2.99
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet (2011) 2.97
Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Ann Neurol (2010) 2.67
The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol (2013) 2.65
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord (2010) 2.34
Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol (2013) 2.30
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol (2010) 2.26
Good outcome in patients with normal-pressure hydrocephalus and factors indicating poor prognosis. J Neurosurg (2005) 2.18
Role of DAT-SPECT in the diagnostic work up of parkinsonism. Mov Disord (2007) 1.96
Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging study. Biol Psychiatry (2013) 1.95
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol (2010) 1.94
Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol (2011) 1.91
Validation of the freezing of gait questionnaire in patients with Parkinson's disease. Mov Disord (2009) 1.90
Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance. Neurobiol Aging (2010) 1.87
Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry (2013) 1.75
Red flags for multiple system atrophy. Mov Disord (2008) 1.75
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. Lancet Neurol (2011) 1.68
Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder. Sleep (2012) 1.68
Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage (2007) 1.63
Mild cognitive impairment after lacunar infarction: voxel-based morphometry and neuropsychological assessment. Cerebrovasc Dis (2007) 1.57
Molecular and clinical prodrome of Parkinson disease: implications for treatment. Nat Rev Neurol (2010) 1.57
Processing of primary and secondary rewards: a quantitative meta-analysis and review of human functional neuroimaging studies. Neurosci Biobehav Rev (2013) 1.55
Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease. Mov Disord (2009) 1.54
Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease. Neurobiol Aging (2007) 1.53
Rapidly progressive diffuse Lewy body disease. Mov Disord (2011) 1.52
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies. J Neurochem (2012) 1.52
Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG). Mov Disord (2006) 1.49
Quantification of electromyographic activity during REM sleep in multiple muscles in REM sleep behavior disorder. Sleep (2008) 1.49
Diagnosis and the premotor phase of Parkinson disease. Neurology (2009) 1.42
Late-stage Parkinson's disease: the Barcelona and Lisbon cohort. J Neurol (2010) 1.41
Cognitive dysfunction and dementia in Parkinson disease. Mov Disord (2007) 1.39
Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage (2003) 1.36
Clinical overview of the synucleinopathies. Mov Disord (2003) 1.36
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord (2010) 1.34
White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann Neurol (2010) 1.34
A cross-sectional and follow-up voxel-based morphometric MRI study in adolescent anorexia nervosa. J Psychiatr Res (2008) 1.31
Dystonia in Parkinson's disease. J Neurol (2006) 1.30
Brain connectivity during resting state and subsequent working memory task predicts behavioural performance. Cortex (2011) 1.26
Modulation of large-scale brain networks by transcranial direct current stimulation evidenced by resting-state functional MRI. Brain Stimul (2011) 1.25
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies. J Neurol Neurosurg Psychiatry (2007) 1.24
LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Arch Neurol (2006) 1.23
Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum Brain Mapp (2011) 1.23
Alterations of the salience network in obesity: a resting-state fMRI study. Hum Brain Mapp (2012) 1.23
The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study). Mov Disord (2014) 1.21
The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord (2014) 1.20
Hippocampal head atrophy after traumatic brain injury. Neuropsychologia (2005) 1.20
Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol (2005) 1.18
Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers. J Alzheimers Dis (2010) 1.18
Repetitive transcranial magnetic stimulation effects on brain function and cognition among elders with memory dysfunction. A randomized sham-controlled study. Cereb Cortex (2005) 1.15
Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT. Mov Disord (2009) 1.15
Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease. Eur J Neurosci (2009) 1.14
Decreased cerebral activation during CPT performance: structural and functional deficits in schizophrenic patients. Neuroimage (2004) 1.13
Resting-state functional magnetic resonance imaging activity and connectivity and cognitive outcome in traumatic brain injury. JAMA Neurol (2013) 1.13
Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord (2004) 1.12
A reassessment of risks and benefits of dopamine agonists in Parkinson's disease. Lancet Neurol (2009) 1.12
Health-related quality of life in multiple system atrophy. Mov Disord (2006) 1.11
A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease. Ann Neurol (2004) 1.11
Mental slowness and executive dysfunctions in patients with metabolic syndrome. Neurosci Lett (2009) 1.09
Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease. Mov Disord (2009) 1.09
Transient arrest of psychogenic tremor induced by contralateral ballistic movements. Neurosci Lett (2004) 1.08
Correlations of thalamic reductions with verbal fluency impairment in those born prematurely. Neuroreport (2006) 1.08
Amygdalar atrophy in panic disorder patients detected by volumetric magnetic resonance imaging. Neuroimage (2003) 1.08
Cortical thinning is associated with disease stages and dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry (2013) 1.07
Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol (2005) 1.07
Premotor signs and symptoms of multiple system atrophy. Lancet Neurol (2012) 1.06
Rapid eye movement sleep behavior disorder in parkinsonism with parkin mutations. Ann Neurol (2004) 1.06
Decreased regional brain volume and cognitive impairment in preterm children at low risk. Pediatrics (2009) 1.06
Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia. J Neurol (2008) 1.05
Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease. J Neurol Sci (2011) 1.05